291 related articles for article (PubMed ID: 8784254)
1. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Zielasek J; Köllner G; Donhauser T; Toyka K; Hartung HP
J Neuroimmunol; 1996 Aug; 68(1-2):1-11. PubMed ID: 8784254
[TBL] [Abstract][Full Text] [Related]
2. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
3. Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats.
Fujimoto T; Sakoda S; Fujimura H; Yanagihara T
J Neuroimmunol; 1999 Mar; 95(1-2):35-42. PubMed ID: 10229113
[TBL] [Abstract][Full Text] [Related]
4. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase.
Martínez I; Puerta C; Redondo C; García-Merino A
J Neurol Sci; 1999 Mar; 164(1):13-23. PubMed ID: 10385042
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
McCombe PA; Harness J; Pender MP
J Neuroimmunol; 1999 Jun; 97(1-2):60-9. PubMed ID: 10408980
[TBL] [Abstract][Full Text] [Related]
7. A new anti-rheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis.
Aikawa Y; Tanuma N; Shin T; Makino S; Tanaka K; Matsumoto Y
J Neuroimmunol; 1998 Aug; 89(1-2):35-42. PubMed ID: 9726823
[TBL] [Abstract][Full Text] [Related]
8. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis.
Athanasas-Platsis S; Zhang B; Hillyard NC; Cavanagh AC; Csurhes PA; Morton H; McCombe PA
J Neurol Sci; 2003 Oct; 214(1-2):27-36. PubMed ID: 12972385
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
11. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
12. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
13. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
15. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
Rott O; Cash E; Fleischer B
Eur J Immunol; 1993 Aug; 23(8):1745-51. PubMed ID: 8393796
[TBL] [Abstract][Full Text] [Related]
17. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.
Weilbach FX; Chan A; Toyka KV; Gold R
Clin Exp Immunol; 2004 Jan; 135(1):49-55. PubMed ID: 14678264
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel.
Cao L; Sun D; Cruz T; Moscarello MA; Ludwin SK; Whitaker JN
J Neuroimmunol; 2000 Aug; 108(1-2):103-11. PubMed ID: 10900343
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein.
Martin D; Near SL; Bendele A; Russell DA
Exp Neurol; 1995 Feb; 131(2):221-8. PubMed ID: 7534720
[TBL] [Abstract][Full Text] [Related]
20. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
